Shareholding disclosure

Straumann Dr. Thomas

Declared position

17.3%

Threshold

Crossed upwards

Timeline

Published

27.11.2012

Transaction

23.11.2012

Transfer date

28.11.2012

Voting rights breakdown

Voting rights acquired17.3%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBCBQ00052

Beneficial owner

Straumann Dr. Thomas

Declared address

Straumann Dr. Thomas, 4125 Riehen

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Straumann Dr. Thomas

Straumann Holding AG27.11.2012TBCBQ00052

Disclosure summary

Straumann Dr. Thomas disclosed a holding in Straumann Holding AG on the acquisition side, published by SIX Exchange Regulation on 27.11.2012, at 17.3% of voting rights. Notice category: Group of shareholders.

Disclosed position

17.3%

Voting rights acquired

Voting rights acquired17.3%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Straumann Dr. Thomas disclosed a holding in Straumann Holding AG, published on 27.11.2012.

Publication date27.11.2012

Transaction date23.11.2012

Transfer date28.11.2012

Issuing companyStraumann Holding AG

Beneficial ownerStraumann Dr. Thomas

Declared addressStraumann Dr. Thomas, 4125 Riehen

CategoryGroup of shareholders

Voting rights acquired17.3%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTBCBQ00052

Source: SIX Exchange Regulation · Publication date: 27.11.2012

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open